| Jessica Wilkinson, MD | |
|
13953 S Bangerter Pkwy, Draper, UT 84020-5429 | |
| (385) 900-4090 | |
| (801) 365-1033 |
| Full Name | Jessica Wilkinson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 13953 S Bangerter Pkwy, Draper, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093179160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 10425611-1205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foothill Clinic, Llc | 9931003795 | 37 |
News Archive
Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye.
Maxim Pharmaceuticals have announced the United States Patent and Trademark Office issued U.S. patent number 6,828,091 B2, entitled "Method of Identifying Immunosuppressive Agents."
New research by the Centre for Environmental Health and Sustainability (CESH) at the University of Leicester indicates that exposure to air pollution from road traffic as early as the first trimester of pregnancy and in early life is associated with small but significant reductions in children's lung function at the age of eight years.
A team of UC Davis investigators has found that a genetic mutation may play an important role in the development of prostate cancer. The mutation of the so-called p53 (or Tp53) gene was previously implicated in late disease progression, but until now has never been shown to act as an initiating factor. The findings may open new avenues for diagnosing and treating the disease.
› Verified 8 days ago
| Entity Name | Foothill Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407947005 PECOS PAC ID: 9931003795 Enrollment ID: O20031122000151 |
News Archive
Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye.
Maxim Pharmaceuticals have announced the United States Patent and Trademark Office issued U.S. patent number 6,828,091 B2, entitled "Method of Identifying Immunosuppressive Agents."
New research by the Centre for Environmental Health and Sustainability (CESH) at the University of Leicester indicates that exposure to air pollution from road traffic as early as the first trimester of pregnancy and in early life is associated with small but significant reductions in children's lung function at the age of eight years.
A team of UC Davis investigators has found that a genetic mutation may play an important role in the development of prostate cancer. The mutation of the so-called p53 (or Tp53) gene was previously implicated in late disease progression, but until now has never been shown to act as an initiating factor. The findings may open new avenues for diagnosing and treating the disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Wilkinson, MD 13953 S Bangerter Pkwy, Draper, UT 84020-5429 Ph: (385) 900-4090 | Jessica Wilkinson, MD 13953 S Bangerter Pkwy, Draper, UT 84020-5429 Ph: (385) 900-4090 |
News Archive
Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye.
Maxim Pharmaceuticals have announced the United States Patent and Trademark Office issued U.S. patent number 6,828,091 B2, entitled "Method of Identifying Immunosuppressive Agents."
New research by the Centre for Environmental Health and Sustainability (CESH) at the University of Leicester indicates that exposure to air pollution from road traffic as early as the first trimester of pregnancy and in early life is associated with small but significant reductions in children's lung function at the age of eight years.
A team of UC Davis investigators has found that a genetic mutation may play an important role in the development of prostate cancer. The mutation of the so-called p53 (or Tp53) gene was previously implicated in late disease progression, but until now has never been shown to act as an initiating factor. The findings may open new avenues for diagnosing and treating the disease.
› Verified 8 days ago
Dr. Gordon Thier Oremland, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12422 S 450 E, Draper, UT 84020 Phone: 801-748-1600 Fax: 801-748-1601 | |
Geoffrey Thomas Osmond, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 11760 S 700 E Ste 112, Draper, UT 84020 Phone: 801-572-1186 | |
Daniel Trevor Young, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 74 E Kimballs Ln Ste 300, Draper, UT 84020 Phone: 801-572-0311 | |
Harold N Gooch, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12176 South 1000 East, Draper, UT 84020 Phone: 801-572-3750 Fax: 801-572-1097 | |
Bradley Prestwich, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12473 S Minuteman Dr, Draper, UT 84020 Phone: 801-495-7910 Fax: 801-495-7990 | |
Dr. Layne A Hermansen, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 877 E 12300 S, Suite 201, Draper, UT 84020 Phone: 801-542-7111 Fax: 801-542-7112 |